November 7, 2025

Castle Biosciences (CSTL) Stock Analysis: A Promising Play in Molecular Diagnostics with an 8.79% Upside

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a current market capitalization of approximately $973.23 million, Castle Biosciences..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Understanding the 38.41% Potential Upside

For investors navigating the intricate landscape of biotechnology stocks, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling opportunity that warrants attention. Headquartered in San Diego, California, Maravai operates primarily..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring the 108% Potential Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) has been making headlines in the biotech sector with its innovative approach to drug discovery and the remarkable potential upside of 108% indicated by analyst..

Xencor, Inc. (XNCR) Stock Analysis: Uncovering a 97.4% Potential Upside in Biotech Innovation

For investors seeking exposure in the healthcare sector, particularly in biotechnology, Xencor, Inc. (NASDAQ: XNCR) presents a compelling opportunity. With a market capitalization just shy of $1 billion, this clinical-stage..

Geron Corporation (GERN) Stock Analysis: A Biotech Play with 235% Potential Upside

Geron Corporation (NASDAQ: GERN), a commercial-stage biopharmaceutical firm, has recently caught the attention of investors, particularly due to its promising upside potential. With a market capitalization of $689.06 million, this..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Exploring a 30% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), a biopharmaceutical company based in Bedford, Massachusetts, is making waves in the healthcare sector with its innovative approach to treating severe genetic diseases. Specializing in..

Cel-Sci Corporation (CVM) Stock Analysis: Biotechnology Innovator with 540% Potential Upside

For investors seeking high-risk, high-reward opportunities, Cel-Sci Corporation (NASDAQ: CVM) presents an intriguing proposition. This clinical-stage biotechnology company, headquartered in Vienna, Virginia, is currently valued at a modest market cap..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: 35% Potential Upside Sparks Investor Interest

Investors looking for opportunities in the healthcare sector may find Treace Medical Concepts, Inc. (NASDAQ: TMCI) a compelling option. With a current market capitalization of $393.57 million, this U.S.-based medical..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges in the Medical Devices Sector

Surmodics, Inc. (NASDAQ: SRDX), a notable player in the healthcare sector, specifically within the medical devices industry, is at a critical juncture that investors should watch closely. With a market..

Praxis Precision Medicines, Inc (PRAX): Stock Analysis Revealing 69.74% Potential Upside in the Biotech Sector

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a beacon in the biotechnology sector, has captivated investor attention with its robust pipeline focused on therapies for central nervous system (CNS) disorders. With..

LifeMD, Inc. (LFMD): Analyst Ratings Signal a 144.77% Upside Potential for This Telehealth Innovator

LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector with its innovative approach to direct-to-patient telehealth services. As a company that bridges the gap between consumers and healthcare..

Replimune Group, Inc. (REPL) Stock Analysis: Exploring a 38% Upside in the Biotech Sector

Replimune Group, Inc. (REPL) presents a compelling case for investors with an appetite for biotech innovation and growth potential. Specializing in oncolytic immunotherapies, Replimune is at the forefront of developing..

Delcath Systems, Inc. (DCTH) Investor Outlook: Unveiling a Potential 172% Upside

Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering entity in the healthcare sector, is drawing considerable attention from investors focused on medical devices. With a market capitalization of $302.24 million, Delcath..

HealthStream, Inc. (HSTM) Stock Analysis: Potential Upside of Over 37% Beckons Investors

HealthStream, Inc. (HSTM), a key player in the health information services industry, has been quietly charting a course for growth, making it a compelling consideration for investors focused on the..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 111.64% Upside in Biotech Innovation

Sana Biotechnology, Inc. (NASDAQ: SANA) presents a compelling opportunity for investors keen on the burgeoning field of biotechnology, with a standout potential upside of 111.64%. Headquartered in Seattle, Washington, this..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Verastem, Inc. (VSTM) Stock Analysis: Biotech Innovator’s 100% Upside Potential Amid Clinical Trials

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with a remarkable potential upside of over 100%, as suggested by recent analyst ratings. This U.S.-based biotechnology firm, with a..

Beta Bionics, Inc. (BBNX)

⚠️ No article content returned.

..

STAAR Surgical Company (STAA) Stock Analysis: Evaluating the Healthcare Player’s Growth Potential Amidst a Volatile Market

STAAR Surgical Company (NASDAQ: STAA) stands as a prominent entity within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Lake Forest, California, and incorporated in..

Definitive Healthcare Corp. (DH): Investor Outlook Reveals 71% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, is garnering investor attention with its potential upside of 71.23%. Specializing in a software as a..

Search

Funds

November 7, 2025

Search

Funds

November 7, 2025

FTSE 100

Funds